Literature DB >> 33955451

So you want to express your protein in Escherichia coli?

Aatir A Tungekar1, Angel Castillo-Corujo1, Lloyd W Ruddock1.   

Abstract

Recombinant proteins have been extensively employed as therapeutics for the treatment of various critical and life-threatening diseases and as industrial enzymes in high-value industrial processes. Advances in genetic engineering and synthetic biology have broadened the horizon of heterologous protein production using multiple expression platforms. Selection of a suitable expression system depends on a variety of factors ranging from the physicochemical properties of the target protein to economic considerations. For more than 40 years, Escherichia coli has been an established organism of choice for protein production. This review aims to provide a stepwise approach for any researcher embarking on the journey of recombinant protein production in E. coli. We present an overview of the challenges associated with heterologous protein expression, fundamental considerations connected to the protein of interest (POI) and designing expression constructs, as well as insights into recently developed technologies that have contributed to this ever-growing field.
© 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  Escherichia coli; bacterial expression; genetic engineering; recombinant proteins; synthetic biology

Mesh:

Substances:

Year:  2021        PMID: 33955451     DOI: 10.1042/EBC20200170

Source DB:  PubMed          Journal:  Essays Biochem        ISSN: 0071-1365            Impact factor:   8.000


  1 in total

1.  Inexpensive protein overexpression driven by the NarL transcription activator protein.

Authors:  Joanne Hothersall; Sandie Lai; Nan Zhang; Rita E Godfrey; Patcharawarin Ruanto; Sarah Bischoff; Colin Robinson; Tim W Overton; Stephen J W Busby; Douglas F Browning
Journal:  Biotechnol Bioeng       Date:  2022-03-06       Impact factor: 4.395

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.